PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Active, not recruiting · NCT02624973 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-02-12 | NCT02624973 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Haukeland University Hospital | 163 |
| Helse Vest | 11 |
| Pfizer | 431 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akershus university hospital | Lørenskog | Norway | 2 |
| Haukeland University Hospital | Bergen | Norway | 2 |
| Helse Fonna | Haugesund | Norway | 1 |
| Helse Førde | Førde | Norway | 1 |
| Helse Nord/UNN | Tromsø | Norway | 1 |
| Helse Stavanger | Stavanger | Norway | 1 |
| St. Olavs Hospital | Trondheim | Norway | 2 |